Monthly Archives: September 2012

Falsely inflated statistics about sex trafficking in the U.S. make bad policy and laws

Share Wasn’t it Mark Twain who said that a lie can travel halfway around the world while the truth is still putting on its shoes? I thought of his famous quote when my husband passed along a link he had … Continue reading

Posted in prostitution, public health, Uncategorized | Tagged , , , , , , , | 2 Comments

Why West Virginia has second highest rate of prescription drug overdoses in the nation

Share Did you know that West Virginia has the second highest rate of deaths from prescription drug overdoses in the country? I didn’t, until I moved to the Mountain State to live and work and became curious as to what … Continue reading

Posted in antidepressants, antipsychotic drugs, drug marketing, health care costs, patient care, pharmaceutical industry, prescription drug overdoes, public health | Tagged , , , , , , , , | 5 Comments

Martin Keller, principal investigator of Paxil study 329, retires from Brown University

Share I just learned that Dr. Martin Keller, principal investigator of the controversial Paxil study 329, has retired from his position as a professor of psychiatry at Brown University — see here.¬†As Pharmalot notes, Keller quietly retired June 30 in … Continue reading

Posted in antidepressants, clinical trials, conflicts of interest, drug marketing, ghostwriting, pharmaceutical industry, scientific journal retractions, scientific misconduct | Tagged , , , , , | 2 Comments

Calls for action against authors of controversial Paxil study are getting louder

Share In the wake of GlaxoSmithKline’s record-breaking $3 billion settlement with the U.S. Department of Justice, a number of psychiatrists and researchers have redoubled their efforts to get Paxil study 329 retracted. As mentioned¬†here and in other news accounts, the … Continue reading

Posted in antidepressants, clinical trials, conflicts of interest, drug marketing, ghostwriting, National Institutes of Health, pharmaceutical industry, scientific journal retractions, scientific misconduct, university industry collaboration | Tagged , , , , , , , | 2 Comments